aTyr Pharma, Inc. (ATYR)

aTyr Pharma Analyst Ratings

ATYR's stock price has decreased by -86.93% in the past year and price targets may not have had time to catch up.

Ratings History

Filter results

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ilya Zubkov Freedom Broker	Freedom Broker	Hold → Strong Buy Upgrades $1 → $3.5	Hold → Strong Buy	Upgrades	$1 → $3.5	+614.29%	May 20, 2026
Brian Abrahams RBC Capital	RBC Capital	Hold Maintains $1.5 → $1	Hold	Maintains	$1.5 → $1	+104.08%	Nov 7, 2025
Ilya Zubkov Freedom Broker	Freedom Broker	Strong Buy → Hold Downgrades $9.5 → $1	Strong Buy → Hold	Downgrades	$9.5 → $1	+104.08%	Sep 19, 2025
Derek Archila Wells Fargo	Wells Fargo	Buy → Hold Downgrades $25 → $1	Buy → Hold	Downgrades	$25 → $1	+104.08%	Sep 16, 2025
Brian Abrahams RBC Capital	RBC Capital	Buy → Hold Downgrades $16 → $1.5	Buy → Hold	Downgrades	$16 → $1.5	+206.12%	Sep 16, 2025
Faisal Khurshid Leerink Partners	Leerink Partners	Buy → Hold Downgrades $1	Buy → Hold	Downgrades	$1	+104.08%	Sep 15, 2025
Soumit Roy Jones Trading	Jones Trading	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Sep 15, 2025
Prakhar Agrawal Cantor Fitzgerald	Cantor Fitzgerald	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Sep 15, 2025

Upgrade to Pro

Get stock forecasts from Wall Street's highest rated professionals

Get much more with Stock Analysis Pro

• Investment ideas from the top Wall Street analysts
• Unlimited access to all data and tools
• Advanced analyst filtering and sorting options
• Up to 3 years of analyst rating history

Analyst Star Rankings

Our analyst star rankings are based on these four factors

Success Rate

The percentage of ratings that are profitable.

Average Return

The average percentage return within one year of the rating.

Rating Count

The more ratings the analyst has provided, the higher the score.

Recency

Ratings provided within the past year contribute to a higher score.